APA (7th ed.) Citation

B, K., L, A., J, J., Y, L., B, L., J, W., . . . HR, S. (2025). CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemia. Frontiers in immunology, 16, 1561823. https://doi.org/10.3389/fimmu.2025.1561823

Chicago Style (17th ed.) Citation

B, Klimovich, et al. "CLEC12A-directed Immunocytokine with Target Cell-restricted IL-15 Activity for Treatment of Acute Myeloid Leukemia." Frontiers in Immunology 16 (2025): 1561823. https://doi.org/10.3389/fimmu.2025.1561823.

MLA (9th ed.) Citation

B, Klimovich, et al. "CLEC12A-directed Immunocytokine with Target Cell-restricted IL-15 Activity for Treatment of Acute Myeloid Leukemia." Frontiers in Immunology, vol. 16, 2025, p. 1561823, https://doi.org/10.3389/fimmu.2025.1561823.